NJ State Employees Deferred Compensation Plan’s West Pharmaceutical WST Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,000	Closed	-$945K	–	475
2017 Q2	$945K	Sell	10,000 -20,000	-67%	-$1.84M	0.18%	183
2017 Q1	$2.45M	Hold	30,000	–	–	0.47%	51
2016 Q4	$2.54M	Hold	30,000	–	–	0.51%	47
2016 Q3	$2.23M	Hold	30,000	–	–	0.46%	55
2016 Q2	$2.28M	Hold	30,000	–	–	0.48%	52
2016 Q1	$2.1M	Hold	30,000	–	–	0.45%	53
2015 Q4	$1.81M	Hold	30,000	–	–	0.37%	75
2015 Q3	$1.62M	Hold	30,000	–	–	0.35%	81
2015 Q2	$1.74M	Hold	30,000	–	–	0.34%	86
2015 Q1	$1.81M	Hold	30,000	–	–	0.35%	78
2014 Q4	$1.6M	Hold	30,000	–	–	0.31%	89
2014 Q3	$1.34M	Hold	30,000	–	–	0.27%	106
2014 Q2	$1.26M	Hold	30,000	–	–	0.25%	121
2014 Q1	$1.32M	Hold	30,000	–	–	0.27%	112
2013 Q4	$1.47M	Hold	30,000	–	–	0.3%	87
2013 Q3	$1.24M	Hold	30,000	–	–	0.27%	108
2013 Q2	$1.05M	Buy	+30,000	New	+$987K	0.24%	119

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's WST Position: Q3 2017 in Review

NJ State Employees Deferred Compensation Plan sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 10,000 shares — an estimated $945K sold.

NJ State Employees Deferred Compensation Plan first reported a position in WST in Q2 2013 and held it in 17 quarters. The position peaked at $2.54M in Q4 2016. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

NJ State Employees Deferred Compensation Plan reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 10,000 West Pharmaceutical shares in Q3 2017, an estimated $945K.
NJ State Employees Deferred Compensation Plan first reported a position in West Pharmaceutical in Q2 2013 and held it in 17 quarters.
NJ State Employees Deferred Compensation Plan's West Pharmaceutical position peaked at $2.54M in Q4 2016.
302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2017, filed 30 Oct 2017.